SLIT3
Basic information
Region (hg38): 5:168661740-169301139
Previous symbols: [ "SLIL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLIT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 27 | 33 | ||||
missense | 111 | 125 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 6 | |||||
Total | 0 | 0 | 114 | 36 | 15 |
Variants in SLIT3
This is a list of pathogenic ClinVar variants found in the SLIT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-168666436-AGGCAGGCG-A | SLIT3-related disorder | Uncertain significance (Sep 08, 2022) | ||
5-168666465-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
5-168666468-G-A | not specified | Uncertain significance (Aug 26, 2022) | ||
5-168666474-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
5-168666520-C-T | SLIT3-related disorder | Likely benign (Jan 01, 2024) | ||
5-168666545-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
5-168666554-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
5-168666571-C-A | SLIT3-related disorder | Uncertain significance (Nov 04, 2022) | ||
5-168666590-C-T | not specified | Likely benign (Oct 05, 2023) | ||
5-168666647-C-T | Benign (Jul 07, 2018) | |||
5-168666648-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
5-168666665-A-C | not specified | Uncertain significance (Jul 16, 2021) | ||
5-168666683-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
5-168669798-C-T | Uncertain significance (Aug 01, 2023) | |||
5-168669810-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
5-168669830-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
5-168669872-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
5-168669923-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
5-168669954-A-G | Uncertain significance (Aug 01, 2023) | |||
5-168669965-G-T | not specified | Uncertain significance (Oct 25, 2022) | ||
5-168671219-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
5-168671228-T-C | not specified | Uncertain significance (Nov 03, 2023) | ||
5-168671230-A-G | Benign (Feb 12, 2021) | |||
5-168671245-G-A | Benign/Likely benign (Jan 01, 2024) | |||
5-168671272-C-T | SLIT3-related disorder | Likely benign (Mar 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLIT3 | protein_coding | protein_coding | ENST00000519560 | 36 | 639389 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.752 | 0.248 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.94 | 742 | 907 | 0.818 | 0.0000561 | 9937 |
Missense in Polyphen | 259 | 372.31 | 0.69566 | 4109 | ||
Synonymous | -0.180 | 398 | 393 | 1.01 | 0.0000265 | 2945 |
Loss of Function | 6.67 | 18 | 83.9 | 0.215 | 0.00000480 | 891 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000932 | 0.0000924 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May act as molecular guidance cue in cellular migration, and function may be mediated by interaction with roundabout homolog receptors.;
- Pathway
- Axon guidance - Homo sapiens (human);Spinal Cord Injury;Developmental Biology;Regulation of commissural axon pathfinding by SLIT and ROBO;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.150
- rvis_EVS
- -2.2
- rvis_percentile_EVS
- 1.37
Haploinsufficiency Scores
- pHI
- 0.828
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.401
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slit3
- Phenotype
- muscle phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; liver/biliary system phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- aortic valve morphogenesis;atrioventricular valve morphogenesis;axon guidance;negative regulation of cell population proliferation;negative regulation of gene expression;chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration;negative regulation of cell growth;cellular response to hormone stimulus;Roundabout signaling pathway;axon extension involved in axon guidance;negative chemotaxis;response to cortisol;ventricular septum morphogenesis;apoptotic process involved in luteolysis;negative regulation of chemokine-mediated signaling pathway
- Cellular component
- extracellular space;mitochondrion
- Molecular function
- calcium ion binding;Roundabout binding